Role of SF3B1 Mutation in Assessment of Acute and Chronic Lymphatic Leukemia
NCT07113132 · Status: NOT_YET_RECRUITING · Type: OBSERVATIONAL · Enrollment: 84
Last updated 2025-08-08
Summary
aim of the work
1. To evaluate the presence of SF3B1-K700E mutation in acute lymphoblastic leukemia and chronic lymphocytic leukemia.
2. To determine the correlation between the presence of SF3B1-K700E mutation with other laboratory findings.
Conditions
- Acute Lymphoblastic Leukemia ALL
- Chronic Lymphocytic Leukemia (CLL)
Sponsors & Collaborators
-
Safaa Ali
lead OTHER
Principal Investigators
-
Sohair m Farghaly, professor · Assiut University
-
Taghred m Kamal El-Din, asst. prof · Assiut University
-
Hebatallah Abdellatif, asst. prof · Assiut University
-
safaa a omran, asst. lect. · Assiut University
Eligibility
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2025-08-01
- Primary Completion
- 2026-07-01
- Completion
- 2027-07-01
More Related Trials
-
Safety and Efficacy of Nilotinib in Newly Diagnosed Chronic Myeloid Leukemia Patients
NCT01254188 ·Status: COMPLETED ·Phase: PHASE3
-
Clinical Outcomes of 3L+ Therapies Among Patients With Chronic Myeloid Leukemia and Those With T315I Mutation
NCT05611216 ·Status: COMPLETED
-
"Peripheral Blood Dipeptidylpeptidase IV (CD26) Positive Leukemic Stem Cells in Chronic Myeloid Leukemia as a Diagnostic Marker"
NCT05543161 ·Status: UNKNOWN
-
Evaluate the Hematological Remission Rates and Survival Among Chinese Adult Patients With B-precursor ALL
NCT03123887 ·Status: COMPLETED
-
Prognostic Value of CD318 in AML at Assiut University Hospital.
NCT04708444 ·Status: UNKNOWN
-
Biomarkers in Young Patients With Acute Myeloid Leukemia
NCT01138332 ·Status: COMPLETED
-
Study of Blood and Tissue Samples in Children With Newly Diagnosed Acute Lymphoblastic Leukemia
NCT01185886 ·Status: UNKNOWN
-
Pharmacogenetic Analysis of Korean Pediatric Patients With Acute Lymphoblastic Leukemia
NCT01556386 ·Status: COMPLETED
-
A Study of GNC-035 in Relapsed or Refractory Chronic Lymphocytic Leukemia and Other Hematological Malignancies
NCT05944978 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1/PHASE2
-
Studying Biomarkers in Cell Samples From Young Patients With Acute Myeloid Leukemia
NCT01057290 ·Status: COMPLETED
-
A Safety Confirmatory Study of Alemtuzumab in Japanese Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia
NCT00923182 ·Status: COMPLETED ·Phase: PHASE1
-
The Safety and Tolerability of LBS-007 in Patients With Relapsed or Resistant Acute Leukaemias
NCT05756322 ·Status: RECRUITING ·Phase: PHASE1/PHASE2
-
Sapanisertib in Treating Patients With Relapsed and/or Refractory Acute Lymphoblastic Leukemia
NCT02484430 ·Status: COMPLETED ·Phase: PHASE2
-
Efficacy and Safety Study of SyB L-0501 for Patients With Chronic Lymphocytic Leukemia
NCT02042911 ·Status: COMPLETED ·Phase: PHASE2
-
Open Study of CEP-701 in Patients With Refractory Acute Myeloid Leukemia With FLT-3 Mutation
NCT00030186 ·Status: COMPLETED ·Phase: PHASE2
-
Biomarkers in Samples From Patients With B-Cell Acute Lymphoblastic Leukemia
NCT01505699 ·Status: COMPLETED
-
Studying Biomarkers as a Diagnostic Tool in Samples From Younger Patients With B-Cell Acute Lymphoblastic Leukemia
NCT01540578 ·Status: COMPLETED
-
Dasatinib in Newly Diagnosed Chronic-Phase Chronic Myeloid Leukemia in Japan
NCT01464411 ·Status: UNKNOWN
-
Efficacy and Safety of LBH589B in Adult Patients With Refractory Chronic Myeloid Leukemia in Accelerated or Blast Phase
NCT00449761 ·Status: TERMINATED ·Phase: PHASE2
-
Observation of the Effect of Chemotherapy Combined With Tyrosinase Inhibitor on the Reactivation of CMV and EBV in Patients With Acute Lymphoblastic Leukemia
NCT03331211 ·Status: UNKNOWN
-
Sorafenib in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, or Chronic Myelogenous Leukemia
NCT00131989 ·Status: COMPLETED ·Phase: PHASE1
-
Patterns of ABL Mutation in Asian With Imatinib Resistant Chronic Myeloid Leukemia and Ph Positive Acute Lymphocytc Leuekmia Patients (AMICA)
NCT02034656 ·Status: UNKNOWN
-
Study of Treatment High Risk and/or Low Risk Acute Lymphoblastic leukémia(ALL) Adults Stage III
NCT00483132 ·Status: COMPLETED ·Phase: PHASE3
-
Expression of Programmed Death-1 (PD-1) & Programmed Death Ligand-1 (PDL-1) in Acute Lymphoblastic Leukemia in Pediatric
NCT05428111 ·Status: UNKNOWN ·Phase: NA
-
Molecular Genetic Lesions and Clinical Outcomes in Children With Acute Lymphoblastic Leukemia
NCT00003291 ·Status: COMPLETED